This web site is part of the Business Intelligence Division of Informa PLC
This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.
Teva Pharmaceutical Industries Ltd.
Drug Names(s): Albuterol HFA (CFC-free), Volare
Description: Albuterol HFA is a non-CFC formulation of albuterol, delivered in a standard metered dose inhaler (MDI). There is also a formulation for the Easi-Breathe breath-activated inhaler.Albuterol is a bronchodilator that relaxes muscles in the airways and increases air flow to the lungs.
Deal Structure: Albuterol HFA was originally developed by Ivax Corporation.
In July 2005, Teva Pharmaceuticals acquired Ivax.
ProAir HFA News
Pink Sheet Ivax HFA Resumes Availability
Pink Sheet Teva winning the albuterol wars
Additional information available to subscribers only: